iRhythm Holdings (IRTC) Cost of Revenue (2015 - 2026)
iRhythm Holdings' (IRTC) quarterly Cost of Revenue came in at $58.0 million in Q1 2026, up 17.34% year-on-year from $49.5 million in Q1 2025, and down 4.6% on a QoQ basis from $60.8 million in Q4 2025.
iRhythm Holdings (IRTC) Cost of Revenue (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has 12 years of Cost of Revenue data on file, last reported at $58.0 million in Q1 2026.
- On a quarterly basis, Cost of Revenue rose 17.34% year-over-year to $58.0 million in Q1 2026; TTM through Mar 2026 was $228.5 million, a 20.65% increase from a year earlier, with the FY2025 full-year figure at $219.9 million, up 19.3% from the prior year.
- Cost of Revenue for Q1 2026 stood at $58.0 million, down from $60.8 million in the prior quarter.
- Over the last five years, Cost of Revenue for IRTC reached as high as $60.8 million in Q4 2025 and fell as low as $30.6 million in Q1 2022.
- Historically, Cost of Revenue has averaged $44.3 million across 5 years, with a median of $44.6 million in 2024.
- Across the five-year window, Cost of Revenue surged 32.95% in 2023 and grew 9.25% in 2024, its largest moves.
- Year by year, Cost of Revenue stood at $33.9 million in 2022, then jumped by 32.95% to $45.1 million in 2023, then climbed by 9.25% to $49.3 million in 2024, then advanced by 23.51% to $60.8 million in 2025, then dropped by 4.6% to $58.0 million in 2026.
- Per Business Quant data, the three most recent Cost of Revenue figures were $58.0 million in Q1 2026, $60.8 million in Q4 2025, and $55.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | iRhythm Holdings | 3.65 Bn | 3.10 Bn | 141.35 Mn | 58.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.04 Mn |
| Mar 31, 2026 | 58.04 Mn |
| Dec 31, 2025 | 60.84 Mn |
| Dec 31, 2025 | 60.84 Mn |
| Sep 30, 2025 | 55.76 Mn |
| Sep 30, 2025 | 55.76 Mn |
| Jun 30, 2025 | 53.83 Mn |
| Jun 30, 2025 | 53.83 Mn |
| Mar 31, 2025 | 49.46 Mn |
| Mar 31, 2025 | 49.46 Mn |
| Dec 31, 2024 | 49.26 Mn |
| Dec 31, 2024 | 49.26 Mn |
| Sep 30, 2024 | 46.06 Mn |
| Sep 30, 2024 | 46.06 Mn |
| Jun 30, 2024 | 44.58 Mn |
| Jun 30, 2024 | 44.58 Mn |
| Mar 31, 2024 | 44.41 Mn |
| Mar 31, 2024 | 44.41 Mn |
| Dec 31, 2023 | 45.09 Mn |
| Dec 31, 2023 | 45.09 Mn |